Anna Shorina

Ms. Anna Shorina


Research Focus & Metrics

Representative Publications

View All Publications
5 November 2026 in Targets
Verified
Journal Article
Open access
PDF file
ASAnna Shorina
Anna Shorina
MPMargarita Pustovalova
Margarita Pustovalova
SLSergey Leonov
Sergey Leonov
Yulia MerkherYulia Merkher
Yulia Merkher
Metastasis is the leading cause of cancer-related mortality, highlighting the need for reliable diagnostic markers and molecular targets that distinguish primary and metastatic tumors. Genes involved in actin cytoskeleton organization and cell mechanics regulate cell migration and invasion and may represent both markers and functional targets of metastatic progression. This study investigated whether copy number alterations (CNAs) in an eleven-gene mechanobiology-related panel (FSCN1, GSN, ACTN4, EZR, CFL1, MYH9, PFN1, TAGLN, ECM1, ANXA2, ANXA6) can distinguish primary from metastatic tumors across breast, pancreatic, and gastric cancers. Publicly available cBioPortal datasets were analyzed using supervised machine-learning algorithms trained on gene-level CNA data. Models trained on combined multicancer datasets showed improved classification performance, evaluated on a held-out breast cancer test set, compared with breast cancer-only training, with Random Forest achieving the highest accuracy (0.851) and F1-score (0.844). Feature importance analysis identified PFN1, ECM1, and FSCN1 as the strongest contributors to metastatic classification, with ANXA6 also showing consistent relevance; permutation importance confirmed PFN1, ANXA6, and FSCN1 in both models. These findings suggest that copy number alterations in mechanobiology-related genes capture genomic patterns associated with metastatic status and may serve as candidate diagnostic biomarkers, warranting further functional and expression-level validation to assess their potential as therapeutic targets.